← All Sponsors
SPONSOR

Eupraxia Pharmaceuticals Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Eosinophilic Esophagitis
NCT05608681 Phase 1, Phase 2
Recruiting

A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

Eosinophilic Esophagitis
Australia, Canada, Netherlands View Trial →